|
|
 |
 |
| News Release |
|
 |

Information in the news releases is current on the date of the announcement, but is subject to change without prior notice. |
| 2001 Release |
 |
| December 19, 2001 |  |
Environmental and Social Report 2001 Released By EISAI Co., Ltd.
|  |
| December 18, 2001 |  |
Settlement Reached with U.S. Direct Purchasers and Acceptance of the Notice from the European Commission Decision Regarding Sales of Bulk Synthetic Vitamin E
|  |
| November 22, 2001 |  |
Notice Received from the European Commission Regarding Sales of Bulk Synthetic Vitamin E
|  |
| November 5, 2001 |  |
CHOCOLA BB ROYAL, a 50 ml Bottle Vitamin B2 Drink Launched By EISAI
|  |
| November 1, 2001 |  |
Eisai Announces Plans to Establish Subsidiary in Spain
|  |
| October 9, 2001 |  |
SELBELLE , A Gastrointestinal Medication Launched By EISAI
|  |
| October 9, 2001 |  |
EISAI Launches BREATHE RIGHT COOL Nasal Strips
|  |
| October 4, 2001 |  |
Notice of Consolidated Interim Period (April 1, 2001 - September 30, 2001) Business Results Forecast Revision
|  |
| September 5, 2001 |  |
EISAI Launches CHOCOLA SAHNE LOTION A Treatment For Dry Itchy Skin
|  |
| September 3, 2001 |  |
Pariet* (rabeprazole) Receives Approval For The Treatment Of Symptomatic GORD In The European Union
|  |
| August 29, 2001 |  |
EISAI U.S.A. Inc. Discontinues U.S. Synthetic Vitamin E and Chemical Operations
|  |
| August 1, 2001 |  |
Notice Relating to the Terms and Conditions of the Stock Option System through New Stock Issuance
|  |
| July 16, 2001 |  |
CHOCOLA BB LIGHT, a 100 ml Bottle Vitamin B2 Drink Launched By EISAI
|  |
| June 25, 2001 |  |
Eisai Introduces a Special R&D Incentive System
|  |
| May 17, 2001 |  |
Notice on Providing Stock Options in the Form of New Stock Issuance ("New Stock Issuance for Stock Option as stipulated by Commercial Law 280-19)
|  |
| April 24, 2001 |  |
Eisai Co., Ltd. and Neurogenetics, Inc. Sign Agreement
|  |
| April 10, 2001 |  |
Eisai Co., Ltd. to License Incyte Genomics Lifeseq Gold Online
|  |
| March 29, 2001 |  |
Eisai Announces Consulting Agreement with Masashi Yanagisawa, M.D., Ph.D. (An Investigator at the Howard Hughes Medical Institute and a University of Texas Professor)
|  |
| March 26, 2001 |  |
Eisai Announces the Establishment of Sunplanet Co., Ltd. A Holding Company for 5 Consolidated Subsidiaries
|  |
| March 21, 2001 |  |
"Don't Surrender to Dementia" Website Opens
|  |
| February 21, 2001 |  |
Notice of Revision of Forecast Year End Dividend For Fiscal Year Period (89th Company Fiscal Period) Ending March 2001
|  |
| January 10, 2001 |  |
Eisai Launches UBITEN S -An Energy and Blood Circulation Improvement Product- |  |
 |  |  |  |
|
|
 |